Q2 2023 Holdings
Filed 2023-08-14 | 70 holdings | $286.3M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-08-21) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals Inc | *W EXP 09/02/202 | 77313F114 | $13.9K | 75,000 | 0.0% |
| Aravive Inc(VSAREUR)Call | COM | 03890D108 | $42.3K | 33,600 | 0.0% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $77.3K | 37,000 | 0.0% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $428.1K | 267,574 | 0.1% |
| NLS Pharmaceutics LTD | SHS | H57830103 | $440.0K | 400,000 | 0.2% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $450.0K | 250,000 | 0.2% |
| Spdr S&P 500 ETF TR(SPY) | TR UNIT | 78462F103 | $488.3K | 18,087 | 0.2% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $490.6K | 20,000 | 0.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $604.3K | 35,133 | 0.2% |
| Talaris Therapeutics Inc | COM | 87410C104 | $608.0K | 200,000 | 0.2% |
| Immatics N.v | *W EXP 07/01/202 | N44445117 | $632.8K | 187,204 | 0.2% |
| Jasper Therapeutics Inc | COM | 471871103 | $653.4K | 476,948 | 0.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $695.3K | 13,923 | 0.2% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $714.3K | 202,349 | 0.2% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $776.1K | 30,000 | 0.3% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $855.2K | 300,068 | 0.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $898.3K | 12,500 | 0.3% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $911.0K | 10,000 | 0.3% |
| Fibrogen Inc(FGENEUR)Call | COM | 31572Q808 | $918.0K | 340,000 | 0.3% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $975.0K | 325,000 | 0.3% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $999.0K | 100,000 | 0.3% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $1.1M | 62,500 | 0.4% |
| Inflarx NV(IFRX) | COM | N44821101 | $1.1M | 240,200 | 0.4% |
| Aravive Inc(VSAREUR)Put | COM | 03890D108 | $1.1M | 861,200 | 0.4% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.2M | 100,000 | 0.4% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $1.2M | 118,891 | 0.4% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $1.3M | 150,000 | 0.4% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $1.3M | 187,675 | 0.4% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $1.3M | 600,000 | 0.5% |
| Precigen Inc | NOTE 3.500% 7/0 | 46122TAA0 | $1.5M | $1,500,000 | 0.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $1.6M | 178,292 | 0.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $1.6M | 125,000 | 0.6% |
| Lianbio | SPONSORED ADS | 53000N108 | $1.8M | 800,676 | 0.6% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $1.9M | 1,492,771 | 0.7% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $2.2M | 4,900,000 | 0.8% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $2.2M | 240,244 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $2.3M | 60,376 | 0.8% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $2.7M | 983,300 | 0.9% |
| Fibrogen Inc(FGENEUR)Put | COM | 31572Q808 | $2.7M | 983,300 | 0.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.0M | 87,031 | 1.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $3.0M | 29,105 | 1.0% |
| Viridian Therapeutics Inc(VRDN)Call | COM | 92790C104 | $3.1M | 130,400 | 1.1% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $3.3M | 100,696 | 1.2% |
| Springworks Therapeutics Inc | COM | 85205L107 | $3.4M | 130,000 | 1.2% |
| Esperion Therapeutics Inc NE | NOTE 4.000%11/1 | 29664WAB1 | $3.4M | $6,925,000 | 1.2% |
| Immatics N.v(IMTX) | SHS | N44445109 | $3.5M | 300,000 | 1.2% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $3.8M | 1,589,017 | 1.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $4.1M | 125,148 | 1.4% |
| Inozyme Pharma Inc | COM | 45790W108 | $4.2M | 751,796 | 1.5% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $4.3M | 60,000 | 1.5% |